| |
NEWS RELEASES
HOUSTON – (April 3, 2009) -
Dr. Huda Zoghbi, internationally renowned neurogeneticist and
director of the
Jan and Dan Duncan Neurological Research Institute
at Texas Children’s Hospital, has been awarded the 2009 Vilcek Prize
in biomedical science for her pioneering research on Rett syndrome
and related autism spectrum disorders. Dr. Zoghbi received the award
during a recent ceremony held at the Mandarin Oriental Hotel in New
York City.
Since its inception in 2006, the Vilcek Prize is presented annually
by the Vilcek Foundation to recognize the contributions of
foreign-born individuals working in the United States in biomedical
science and in the arts. As a 2009 Vilcek prize honoree, Dr. Zoghbi
received a $50,000 cash award and a commemorative trophy created by
designer Stefan Sagmeister. This year’s Vilcek Prize in the arts was
awarded to famed stage and screen director Mike Nichols at the same
ceremony.
| |
 |
| |
Dr. Huda Zoghbi
receipient of the 2009 Vilcek Prize in Biomedical
Research, with Jan and Marica Vilcek, Cofounders, The
Vilcek Foundation |
“I am deeply honored by this award and very grateful to the Vilcek
Foundation for their efforts to promote awareness of ongoing
research and advancements in biomedical science,” said Dr. Zoghbi.
Dr. Zoghbi is a specialist
in Texas Children’s Neurology Service, holds full professorships in
the Departments of Pediatrics, Neuroscience, and Molecular and Human
Genetics at Baylor College of Medicine, and is an Investigator with
the Howard Hughes Medical Institute.
Her work first made headlines when she co-discovered the gene that
causes spinocerebellar ataxia type 1, a crippling neurological
disease. She and her team then discovered that mutations in MeCP2
cause the neurodevelopmental disorder Rett syndrome, an autism
spectrum disorder. She and her colleagues also identified the gene
Math 1 that regulates the growth of tiny inner ear hair cells,
essential elements of hearing and balance in mammals.
Dr. Zoghbi’s recent research advances include deciphering some of
the molecular mechanisms that underlie Rett syndrome and SCA1, and
the identification of a potential therapy that has subdued SCA1
symptoms in animal models as a first step for preparations of
translational studies in humans.
Dr. Zoghbi will soon lead Texas Children’s groundbreaking pediatric
neurological research from its newly built neurological research
institute, scheduled to open in 2010. This innovative facility will
serve as the crossroads where more than 170 researchers, across over
15 disciplines, will collaborate to bring promising new treatments
to those afflicted with neurological diseases.
Born in Beirut, Lebanon, Dr. Zoghbi’s journey to medical renown
began when her first semester of medical school at the American
University in Beirut was shattered by civil war. Determined to
finish the year, she and her fellow students and their professors
lived in the basement of the medical school building, attending
class in “safe” rooms with double-thick walls. Her parents convinced
her to move to the United States for safety reasons and she
completed her medical studies at Nashville's Meharry Medical
College, graduating in 1979. She completed her pediatric residency
as well as a residency in pediatric neurology at Baylor College of
Medicine in Houston. Seeing children with incurable, inherited
neurologic diseases piqued her interest in research and led her to
take on a postdoctoral fellowship in molecular genetics. She trained
with Dr. Arthur L. Beaudet in the Department of Molecular and Human
Genetics at Baylor and joined the college’s faculty as an assistant
professor in 1988.
Dr. Zoghbi is a member of
several professional organizations and serves on the editorial
boards of a number of prominent journals. Her honors include the
Sidney Carter Award from the American Academy of Neurology; the
Derek Denny-Brown Neurological Scholar Award from the American
Neurological Association; the E. Mead Johnson Award from Society of
Pediatric Research—the nation’s most distinguished pediatric
research award; the Bernard Sachs Award from the Child Neurology
Society; the Kilby Award for Extraordinary Contributions to Society
through Science, Technology, Innovation, Invention, and Education;
the IPSEN prize in neuronal plasticity; the Javits Award from the
National Institutes of Health; and the Bristol Myers-Squibb
Neuroscience Distinguished Achievement Award. In 2000 she was
elected to the Institute of Medicine, and in 2004 she was elected to
the National Academy of Sciences.
About the Jan and Dan Duncan Neurological Research Institute at
Texas Children’s Hospital Recognizing there was no single
institution using multidisciplinary research to guide the study of
pediatric cognitive development and neurological disorders, Texas
Children’s Hospital created the Jan and Dan Duncan Neurological
Research Institute. Scheduled to open in 2010, the institute will be
the first dedicated facility to use a multidisciplinary research
approach to rapidly accelerate the search for treatments for
pediatric neurological disorders. The specially-designed facility
will be the crossroads where more than 170 researchers (over 15
principal investigators and their teams) across disciplines
collaborate to bring promising new therapies to those afflicted with
neurological diseases.
About Texas Children’s Hospital
Texas Children's Hospital is committed to a community of healthy
children by providing the finest pediatric patient care, education
and research. Renowned worldwide for its expertise and breakthrough
developments in clinical care and research, Texas Children’s is
ranked in the top ten best children’s hospitals by U.S. News & World
Report. Texas Children’s also operates the nation’s largest primary
pediatric care network, with over 40 offices throughout the greater
Houston community. Texas Children’s has embarked on a $1.5 billion
expansion,
Vision
2010, which includes a neurological research institute, a
comprehensive obstetrics facility focusing on high-risk births and a
community hospital in suburban West Houston. For more information on
Texas Children's Hospital, visit
www.texaschildrens.org.
|
|